Delegation of Authority to the Chief Accountant, 2805-2807 [2011-835]

Download as PDF 2805 Federal Register / Vol. 76, No. 11 / Tuesday, January 18, 2011 / Rules and Regulations Accordingly, part 748 of the EAR (15 CFR Parts 730–774) is amended as follows: PART 748—[AMENDED] 1. The authority citation for 15 CFR Part 748 continues to read as follows: ■ Authority: 50 U.S.C. app. 2401 et seq.; 50 U.S.C. 1701 et seq.; E.O. 13026, 61 FR 58767, 3 CFR, 1996 Comp., p. 228; E.O. 13222, 66 FR 44025, 3 CFR, 2001 Comp., p. 783; Notice of August 12, 2010, 75 FR 50681 (August 16, 2010). ‘‘China (People’s Republic of)’’ to read as follows: 2. Supplement No. 7 to Part 748 is amended: ■ a. By adding one entry, ‘‘CSMC Technologies Corporation’’, for ‘‘China (People’s Republic of)’’ in alphabetical order; and ■ b. By revising the entry for ‘‘Advanced Micro Devices (Shanghai) Co., Ltd.’’ for SUPPLEMENT NO. 7 TO PART 748— AUTHORIZATION VALIDATED ENDUSER (VEU); LIST OF VALIDATED END-USERS, RESPECTIVE ITEMS ELIGIBLE FOR EXPORT, REEXPORT AND TRANSFER, AND ELIGIBLE DESTINATIONS ■ Country Validated end-user Eligible items (by ECCN) Eligible destination China (People’s Republic of). Advanced Micro Devices China, Inc. ....................... 3D002, 3D003, 3E001 (limited to ‘‘technology’’ for items classified under 3C002 and 3C004 and ‘‘technology’’ for use during the International Technology Roadmap for Semiconductors (ITRS) process for items classified under ECCNs 3B001 and 3B002), 3E002 (limited to ‘‘technology’’ for use during the ITRS process for items classified under ECCNs 3B001 and 3B002), 3E003.e (limited to the ‘‘development’’ and ‘‘production’’ of integrated circuits for commercial applications), 4D001, 4D002, 4D003 and 4E001 (limited to the ‘‘development’’ of products under ECCN 4A003). AMD Technologies (China) Co., Ltd., No. 88, Su Tong Road, Suzhou, China 215021. Advanced Micro Devices (Shanghai) Co., Ltd., Buildings 46, 47, 48 & 49, River Front Harbor, Zhangjiang Hi-Tech Park, 1387 Zhangdong Rd., Pudong, Shanghai, 201203. AMD Technology Development (Beijing) Co., Ltd., 18F, North Building, Raycom Infotech, Park Tower C, No. 2 Science Institute South Rd., Zhong Guan Cun, Haidian District, Beijing, China 100190. * * * * CSMC Technologies Corporation ............................. 1C350.c.3, 1C350.c.11, 2B230.a, 2B230.b, 2B350.f, 2B350.g, 2B350.h, 3B001.c.1.a, 3B001.c.2.a, 3B001.e, 3C002.a, 3C004. * * CSMC Technologies Fab 1 Co., Ltd., 14 Liangxi Road, Wuxi, Jiangsu 214061, China. CSMC, Technologies Fab 2 Co., Ltd., Block 86, 87, Wuxi National Hi-New Tech Industrial Development Zone, Wuxi, Jiangsu 214061, China. Wuxi CR Semiconductor Wafers and Chips Co., Ltd., 14 Liangxi Road, Wuxi, Jiangsu 214061, China. * * * * Dated: January 11, 2011. Kevin J. Wolf, Assistant Secretary for Export Administration. BILLING CODE 3510–33–P SECURITIES AND EXCHANGE COMMISSION WReier-Aviles on DSKDVH8Z91PROD with RULES 17 CFR Part 200 [Release No. 34–63699] Delegation of Authority to the Chief Accountant Securities and Exchange Commission. ACTION: Final rule. AGENCY: 13:37 Jan 14, 2011 * The Securities and Exchange Commission is amending its rules to delegate authority to the Chief Accountant with respect to proposed rule changes of the Public Company Accounting Oversight Board pursuant to Section 107 of the Sarbanes-Oxley Act of 2002 and Section 19(b) of the Securities Exchange Act of 1934, as follows: To publish notices of proposed rule changes filed by the PCAOB; to approve or disapprove a proposed rule change; and to temporarily suspend a proposed rule of the PCAOB. In addition, the Commission is amending its rules to delegate authority to the Chief Accountant to determine the appropriateness of extending the time periods specified in Section 19(b) and publish the reasons for such determination as well as to effect any SUMMARY: [FR Doc. 2011–920 Filed 1–14–11; 8:45 am] VerDate Mar<15>2010 * Jkt 223001 PO 00000 Frm 00007 Fmt 4700 Sfmt 4700 * * such extension and to institute proceedings to determine whether to disapprove a proposal and to provide to the PCAOB notice of the grounds for disapproval under consideration, and to find good cause to approve a proposal on an accelerated basis and to publish the reasons for such determination. This delegation is intended to conserve Commission resources and to maintain the effectiveness and efficiency of the Commission’s PCAOB proposed rule filing process. DATES: Effective Date: January 18, 2011. FOR FURTHER INFORMATION CONTACT: Jeffrey S. Cohan, Senior Special Counsel, or John F. Offenbacher, Senior Associate Chief Accountant, at (202) 551–5300, Office of the Chief Accountant, Securities and Exchange E:\FR\FM\18JAR1.SGM 18JAR1 2806 Federal Register / Vol. 76, No. 11 / Tuesday, January 18, 2011 / Rules and Regulations Commission, 100 F Street, NE., Washington, DC 20549–7561. SUPPLEMENTARY INFORMATION: WReier-Aviles on DSKDVH8Z91PROD with RULES I. Discussion of Rule Amendments Pursuant to the Sarbanes-Oxley Act of 2002 (‘‘Sarbanes-Oxley Act’’),1 proposed rules of the Public Company Accounting Oversight Board (‘‘PCAOB’’) are governed by certain provisions of Section 19 of the Securities Exchange Act of 1934 (‘‘Exchange Act’’).2 The Dodd-Frank Wall Street Reform and Consumer Protection Act 3 amended Section 19 of the Exchange Act so that there are new deadlines by which the Securities and Exchange Commission (‘‘Commission’’) must publish and act upon proposed rule changes submitted by the PCAOB. In recognition of the amendments to Section 19, the Commission is amending its rules governing delegations of authority to the Chief Accountant. The amendments to Rule 30–11 (17 CFR 200.30–11) authorize the Chief Accountant: (1) To publish notice of a PCAOB proposed rule change pursuant to Section 19(b)(1); (2) pursuant to Section 19(b)(2) of the Exchange Act, to approve or disapprove 4 a PCAOB proposed rule change; 5 (3) pursuant to Section 19(b)(2)(A) of the Exchange Act,6 to extend for a period not exceeding 90 days from the date of publication of notice of the filing of a proposed rule change the period during which the Commission must by order approve or disapprove the proposed rule change; (4) pursuant to Section 19(b)(2)(A) of the Exchange Act,7 to determine the appropriateness of extending the period during which the Commission must by 1 See Section 107 of the Sarbanes-Oxley Act, 15 U.S.C. 7217. 2 See 15 U.S.C. 78s(b)(2). 3 Dodd-Frank Wall Street Reform and Consumer Protection Act, Pub. L. 111–203, 124 Stat. 1376 (2010). 4 15 U.S.C. 78s(b)(2). Section 107(b) of the Sarbanes Oxley Act, 15 U.S.C. 7217(b), and Section 19(b)(2)(C) of the Exchange Act, 15 U.S.C. 78s(b)(2)(C), provide the standards for Commission approval and disapproval of a proposed rule. Specifically, Section 107(b)(3) provides that the Commission ‘‘shall approve a proposed rule if it finds that the rule is consistent with the requirements of this Act and the securities laws, or is necessary and appropriate in the public interest or for the protection of investors.’’ Additionally, the Commission may not approve a proposed rule change earlier than 30 days after the date of publication unless the Commission finds good cause for so doing and publishes the reasons for the finding. 5 The amendments also specify that the Office of the Chief Accountant is to notify the Commission no less than five (5) business days before the Chief Accountant intends to exercise his or her authority to approve or disapprove a particular proposed rule change. 6 15 U.S.C. 78s(b)(2)(A). 7 15 U.S.C. 78s(b)(2)(A). VerDate Mar<15>2010 13:37 Jan 14, 2011 Jkt 223001 order approve or disapprove a proposed rule change or institute proceedings to determine whether to disapprove the proposal and publish the reasons for such determination; (5) pursuant to Section 19(b)(2)(B) of the Exchange Act,8 to extend for a period not exceeding 240 days from the date of publication of notice of the filing of a proposed rule change the period during which the Commission must conclude proceedings to determine whether to disapprove the proposal and to determine whether such longer period is appropriate and publish the reasons for such determination; (6) to temporarily suspend the PCAOB’s proposed rule change pursuant to Section 19(b)(3)(C) of the Exchange Act; 9 (7) pursuant to Section 19(b)(2) of the Exchange Act and 19(b)(3) of the Exchange Act, to institute proceedings to determine whether a proposed rule of the PCAOB should be disapproved and to provide to the PCAOB notice of the grounds for disapproval under consideration; and (8) to find good cause to approve a proposal on an accelerated basis and to publish the reasons for such determination. This delegation is intended to conserve Commission resources and maintain the effectiveness and efficiency of the Commission’s process for handling proposed rule changes submitted by the PCAOB. The Commission anticipates that the delegation of authority will help facilitate timely compliance with the amendments to Section 19 of the Exchange Act and the new statutory deadlines prescribed therein. Nevertheless, the Chief Accountant may submit matters to the Commission for its consideration, as he or she deems appropriate. The Commission finds, in accordance with the Administrative Procedure Act (5 U.S.C. 553(b)(3)(A)), that these amendments relate solely to agency organization, procedures, or practices, and do not relate to a substantive rule. Accordingly, notice, opportunity for public comment, and publication of the amendments prior to their effective date are unnecessary and these changes are effective on January 18, 2011. List of Subjects in 17 CFR Part 200 Administrative practice and procedure, Authority delegations (Government agencies). Text of Amendment For the reasons set out in the preamble, Title 17, Chapter II of the 8 15 9 15 PO 00000 U.S.C. 78s(b)(2)(B). U.S.C. 78s(b)(3)(C). Frm 00008 Fmt 4700 Sfmt 4700 Code of Federal Regulations is amended as follows: PART 200—ORGANIZATION; CONDUCT AND ETHICS; AND INFORMATION AND REQUESTS 1. The authority citation for Part 200, Subpart A, continues to read in part as follows: ■ Authority: 15 U.S.C. 77o, 77s, 77sss, 77d, 78d–1, 78d–2, 78w, 78ll(d), 78mm, 80a–37, 80b–11, and 7202 et seq., unless otherwise noted. * * * * * 2. Section 200.30–11 is amended as follows: ■ a. Redesignating paragraph (b) as paragraph (c). ■ b. Adding new paragraph (b). The addition reads as follows: ■ § 200.30–11 Delegation of authority to the Chief Accountant. * * * * * (b)(1) Pursuant to section 107 of the Sarbanes-Oxley Act of 2002, 15 U.S.C. 7217, and section 19(b) of the Act, 15 U.S.C. 78s(b), and applicable rules of the Commission, to publish notices of proposed rule changes filed by the Public Company Accounting Oversight Board. (2) Pursuant to section 107 of the Sarbanes-Oxley Act of 2002, 15 U.S.C. 7217, and section 19(b) of the Act, 15 U.S.C. 78s(b), and applicable rules of the Commission, to approve or disapprove a proposed rule change, and to find good cause to approve a proposed rule change earlier than 30 days after the date of publication of such proposed rule change and to publish the reasons for such finding. The Office of the Chief Accountant shall notify the Commission no less than five (5) business days before the Chief Accountant intends to exercise his or her authority to approve or disapprove a particular proposed rule change. (3) Pursuant to section 107 of the Sarbanes-Oxley Act of 2002, 15 U.S.C. 7217, and section 19(b)(2)(A) of the Act, 15 U.S.C. 78s(b)(2)(A), to extend for a period not exceeding 90 days from the date of publication of notice of the filing of a proposed rule change pursuant to section 19(b)(1) of the Act, 15 U.S.C. 78s(b)(1), the period during which the Commission must by order approve or disapprove the proposed rule change or institute proceedings to determine whether the proposed rule change should be disapproved and to determine whether such longer period is appropriate and publish the reasons for such determination. (4) Pursuant to section 107 of the Sarbanes-Oxley Act of 2002, 15 U.S.C. E:\FR\FM\18JAR1.SGM 18JAR1 2807 Federal Register / Vol. 76, No. 11 / Tuesday, January 18, 2011 / Rules and Regulations 7217, section 19(b)(2) of the Act, 15 U.S.C. 78s(b)(2), and section 19(b)(3) of the Act, 15 U.S.C. 78s(b)(3), to institute proceedings to determine whether a proposed rule change of the Public Company Accounting Oversight Board should be disapproved and to provide to the Public Company Accounting Oversight Board notice of the grounds for disapproval under consideration. In addition, pursuant to section 107 of the Sarbanes-Oxley Act of 2002, 15 U.S.C. 7217, and section 19(b)(2)(B) of the Act, 15 U.S.C. 78s(b)(2)(B), to extend for a period not exceeding 240 days from the date of publication of notice of the filing of a proposed rule change pursuant to section 19(b)(1) of the Act, 15 U.S.C. 78s(b)(1), the period during which the Commission must issue an order approving or disapproving the proposed rule change and to determine whether such longer period is appropriate and publish the reasons for such determination. (5) Pursuant to section 107 of the Sarbanes-Oxley Act of 2002, 15 U.S.C. 7217, and section 19(b)(3)(C) of the Act, 15 U.S.C. 78s(b)(3)(C), to temporarily suspend a rule of the Public Company Accounting Oversight Board. * * * * * Dated: January 11, 2011. By the Commission. Elizabeth M. Murphy, Secretary. Biopure Corp., 11 Hurley St., Cambridge, MA 02141 has informed FDA that it has transferred ownership of, and all rights and interest in, NADA 141–067 for OXYGLOBIN (hemoglobin glutamer200) to OPK Biotech, LLC, 11 and 39 Hurley St., Cambridge, MA 02141. There is no change in drug labeler code. Following this change of sponsorship, Biopure Corp. is no longer the sponsor of an approved application. In addition, OPK Biotech, LLC, is not currently listed in the animal drug regulations as a sponsor of an approved application. Accordingly, § 510.600 is being amended to reflect these changes. This rule does not meet the definition of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because it is a rule of ‘‘particular applicability.’’ Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801–808. SUPPLEMENTARY INFORMATION: List of Subjects in 21 CFR Part 510 Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is amended as follows: [FR Doc. 2011–835 Filed 1–14–11; 8:45 am] 1. The authority citation for 21 CFR part 510 continues to read as follows: ■ Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e. DEPARTMENT OF HEALTH AND HUMAN SERVICES 21 CFR Part 510 [Docket No. FDA–2010–N–0002] New Animal Drugs; Change of Sponsor AGENCY: Food and Drug Administration, HHS. ACTION: 2. In § 510.600, in the table in paragraph (c)(1), remove the entry for ‘‘Biopure Corp.’’; and alphabetically add a new entry for ‘‘OPK Biotech, LLC’’; and in the table in paragraph (c)(2), revise the entry for ‘‘063075’’ to read as follows: ■ Food and Drug Administration Final rule. § 510.600 Names, addresses, and drug labeler codes of sponsors of approved applications. * The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for hemoglobin glutamer-200 from Biopure Corp. to OPK Biotech, LLC. DATES: This rule is effective January 18, 2011. FOR FURTHER INFORMATION CONTACT: Steven D. Vaughn, Center for Veterinary Medicine (HFV–100), Food and Drug Administration, 7520 Standish Pl., Rockville, MD 20855, 240–276–8300, e-mail: steven.vaughn@fda.hhs.gov. WReier-Aviles on DSKDVH8Z91PROD with RULES SUMMARY: VerDate Mar<15>2010 13:59 Jan 14, 2011 Jkt 223001 * * (c) * * * (1) * * * * * Drug labeler code Firm name and address * * * * OPK Biotech, LLC, 11 and 39 Hurley St., Cambridge, MA 02141 ........................................ PO 00000 * * * * (2) * * * Frm 00009 Fmt 4700 Sfmt 4700 Firm name and address * 063075 * * * * OPK Biotech, LLC, 11 and 39 Hurley St., Cambridge, MA 02141 * * * 063075 * * * * Dated: January 11, 2011. Steven D. Vaughn, Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine. [FR Doc. 2011–904 Filed 1–14–11; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Parts 510 and 522 [Docket No. FDA–2010–N–0002] New Animal Drugs; Change of Sponsor; Follicle Stimulating Hormone AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for a new animal drug application (NADA) for follicle stimulating hormone from Ausa International, Inc., to Therio, Inc. DATES: This rule is effective January 18, 2011. FOR FURTHER INFORMATION CONTACT: Steven D. Vaughn, Center for Veterinary Medicine (HFV–100), Food and Drug Administration, 7520 Standish Pl., Rockville, MD 20855, 240–276–8300, e-mail: steven.vaughn@fda.hhs.gov. SUPPLEMENTARY INFORMATION: Ausa International, Inc., Rt. 8, P.O. Box 324– 12, Tyler, TX 75703 has informed FDA that it has transferred ownership of, and all rights and interest in, NADA 141– 014 for SUPER–OV (follicle stimulating hormone) to Therio, Inc., 8801 Anderson Ave., Manhattan, KS 66503. Accordingly, the Agency is amending the regulations in 21 CFR 522.1002 to reflect the transfer of ownership. Following this change of sponsorship, Ausa International, Inc., is no longer the sponsor of an approved application. Accordingly, § 510.600 (21 CFR 510.600) is being amended to remove the entries for this firm. SUMMARY: PART 510—NEW ANIMAL DRUGS BILLING CODE 8011–01–P Drug labeler code E:\FR\FM\18JAR1.SGM 18JAR1

Agencies

[Federal Register Volume 76, Number 11 (Tuesday, January 18, 2011)]
[Rules and Regulations]
[Pages 2805-2807]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-835]


=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

17 CFR Part 200

[Release No. 34-63699]


Delegation of Authority to the Chief Accountant

AGENCY: Securities and Exchange Commission.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: The Securities and Exchange Commission is amending its rules 
to delegate authority to the Chief Accountant with respect to proposed 
rule changes of the Public Company Accounting Oversight Board pursuant 
to Section 107 of the Sarbanes-Oxley Act of 2002 and Section 19(b) of 
the Securities Exchange Act of 1934, as follows: To publish notices of 
proposed rule changes filed by the PCAOB; to approve or disapprove a 
proposed rule change; and to temporarily suspend a proposed rule of the 
PCAOB. In addition, the Commission is amending its rules to delegate 
authority to the Chief Accountant to determine the appropriateness of 
extending the time periods specified in Section 19(b) and publish the 
reasons for such determination as well as to effect any such extension 
and to institute proceedings to determine whether to disapprove a 
proposal and to provide to the PCAOB notice of the grounds for 
disapproval under consideration, and to find good cause to approve a 
proposal on an accelerated basis and to publish the reasons for such 
determination. This delegation is intended to conserve Commission 
resources and to maintain the effectiveness and efficiency of the 
Commission's PCAOB proposed rule filing process.

DATES:  Effective Date: January 18, 2011.

FOR FURTHER INFORMATION CONTACT: Jeffrey S. Cohan, Senior Special 
Counsel, or John F. Offenbacher, Senior Associate Chief Accountant, at 
(202) 551-5300, Office of the Chief Accountant, Securities and Exchange

[[Page 2806]]

Commission, 100 F Street, NE., Washington, DC 20549-7561.

SUPPLEMENTARY INFORMATION:

I. Discussion of Rule Amendments

    Pursuant to the Sarbanes-Oxley Act of 2002 (``Sarbanes-Oxley 
Act''),\1\ proposed rules of the Public Company Accounting Oversight 
Board (``PCAOB'') are governed by certain provisions of Section 19 of 
the Securities Exchange Act of 1934 (``Exchange Act'').\2\ The Dodd-
Frank Wall Street Reform and Consumer Protection Act \3\ amended 
Section 19 of the Exchange Act so that there are new deadlines by which 
the Securities and Exchange Commission (``Commission'') must publish 
and act upon proposed rule changes submitted by the PCAOB. In 
recognition of the amendments to Section 19, the Commission is amending 
its rules governing delegations of authority to the Chief Accountant. 
The amendments to Rule 30-11 (17 CFR 200.30-11) authorize the Chief 
Accountant: (1) To publish notice of a PCAOB proposed rule change 
pursuant to Section 19(b)(1); (2) pursuant to Section 19(b)(2) of the 
Exchange Act, to approve or disapprove \4\ a PCAOB proposed rule 
change; \5\ (3) pursuant to Section 19(b)(2)(A) of the Exchange Act,\6\ 
to extend for a period not exceeding 90 days from the date of 
publication of notice of the filing of a proposed rule change the 
period during which the Commission must by order approve or disapprove 
the proposed rule change; (4) pursuant to Section 19(b)(2)(A) of the 
Exchange Act,\7\ to determine the appropriateness of extending the 
period during which the Commission must by order approve or disapprove 
a proposed rule change or institute proceedings to determine whether to 
disapprove the proposal and publish the reasons for such determination; 
(5) pursuant to Section 19(b)(2)(B) of the Exchange Act,\8\ to extend 
for a period not exceeding 240 days from the date of publication of 
notice of the filing of a proposed rule change the period during which 
the Commission must conclude proceedings to determine whether to 
disapprove the proposal and to determine whether such longer period is 
appropriate and publish the reasons for such determination; (6) to 
temporarily suspend the PCAOB's proposed rule change pursuant to 
Section 19(b)(3)(C) of the Exchange Act; \9\ (7) pursuant to Section 
19(b)(2) of the Exchange Act and 19(b)(3) of the Exchange Act, to 
institute proceedings to determine whether a proposed rule of the PCAOB 
should be disapproved and to provide to the PCAOB notice of the grounds 
for disapproval under consideration; and (8) to find good cause to 
approve a proposal on an accelerated basis and to publish the reasons 
for such determination.
---------------------------------------------------------------------------

    \1\ See Section 107 of the Sarbanes-Oxley Act, 15 U.S.C. 7217.
    \2\ See 15 U.S.C. 78s(b)(2).
    \3\ Dodd-Frank Wall Street Reform and Consumer Protection Act, 
Pub. L. 111-203, 124 Stat. 1376 (2010).
    \4\ 15 U.S.C. 78s(b)(2). Section 107(b) of the Sarbanes Oxley 
Act, 15 U.S.C. 7217(b), and Section 19(b)(2)(C) of the Exchange Act, 
15 U.S.C. 78s(b)(2)(C), provide the standards for Commission 
approval and disapproval of a proposed rule. Specifically, Section 
107(b)(3) provides that the Commission ``shall approve a proposed 
rule if it finds that the rule is consistent with the requirements 
of this Act and the securities laws, or is necessary and appropriate 
in the public interest or for the protection of investors.'' 
Additionally, the Commission may not approve a proposed rule change 
earlier than 30 days after the date of publication unless the 
Commission finds good cause for so doing and publishes the reasons 
for the finding.
    \5\ The amendments also specify that the Office of the Chief 
Accountant is to notify the Commission no less than five (5) 
business days before the Chief Accountant intends to exercise his or 
her authority to approve or disapprove a particular proposed rule 
change.
    \6\ 15 U.S.C. 78s(b)(2)(A).
    \7\ 15 U.S.C. 78s(b)(2)(A).
    \8\ 15 U.S.C. 78s(b)(2)(B).
    \9\ 15 U.S.C. 78s(b)(3)(C).
---------------------------------------------------------------------------

    This delegation is intended to conserve Commission resources and 
maintain the effectiveness and efficiency of the Commission's process 
for handling proposed rule changes submitted by the PCAOB. The 
Commission anticipates that the delegation of authority will help 
facilitate timely compliance with the amendments to Section 19 of the 
Exchange Act and the new statutory deadlines prescribed therein. 
Nevertheless, the Chief Accountant may submit matters to the Commission 
for its consideration, as he or she deems appropriate.
    The Commission finds, in accordance with the Administrative 
Procedure Act (5 U.S.C. 553(b)(3)(A)), that these amendments relate 
solely to agency organization, procedures, or practices, and do not 
relate to a substantive rule. Accordingly, notice, opportunity for 
public comment, and publication of the amendments prior to their 
effective date are unnecessary and these changes are effective on 
January 18, 2011.

List of Subjects in 17 CFR Part 200

    Administrative practice and procedure, Authority delegations 
(Government agencies).

Text of Amendment

    For the reasons set out in the preamble, Title 17, Chapter II of 
the Code of Federal Regulations is amended as follows:

PART 200--ORGANIZATION; CONDUCT AND ETHICS; AND INFORMATION AND 
REQUESTS

0
1. The authority citation for Part 200, Subpart A, continues to read in 
part as follows:

    Authority:  15 U.S.C. 77o, 77s, 77sss, 77d, 78d-1, 78d-2, 78w, 
78ll(d), 78mm, 80a-37, 80b-11, and 7202 et seq., unless otherwise 
noted.
* * * * *

0
2. Section 200.30-11 is amended as follows:
0
a. Redesignating paragraph (b) as paragraph (c).
0
b. Adding new paragraph (b).
    The addition reads as follows:


Sec.  200.30-11  Delegation of authority to the Chief Accountant.

* * * * *
    (b)(1) Pursuant to section 107 of the Sarbanes-Oxley Act of 2002, 
15 U.S.C. 7217, and section 19(b) of the Act, 15 U.S.C. 78s(b), and 
applicable rules of the Commission, to publish notices of proposed rule 
changes filed by the Public Company Accounting Oversight Board.
    (2) Pursuant to section 107 of the Sarbanes-Oxley Act of 2002, 15 
U.S.C. 7217, and section 19(b) of the Act, 15 U.S.C. 78s(b), and 
applicable rules of the Commission, to approve or disapprove a proposed 
rule change, and to find good cause to approve a proposed rule change 
earlier than 30 days after the date of publication of such proposed 
rule change and to publish the reasons for such finding. The Office of 
the Chief Accountant shall notify the Commission no less than five (5) 
business days before the Chief Accountant intends to exercise his or 
her authority to approve or disapprove a particular proposed rule 
change.
    (3) Pursuant to section 107 of the Sarbanes-Oxley Act of 2002, 15 
U.S.C. 7217, and section 19(b)(2)(A) of the Act, 15 U.S.C. 
78s(b)(2)(A), to extend for a period not exceeding 90 days from the 
date of publication of notice of the filing of a proposed rule change 
pursuant to section 19(b)(1) of the Act, 15 U.S.C. 78s(b)(1), the 
period during which the Commission must by order approve or disapprove 
the proposed rule change or institute proceedings to determine whether 
the proposed rule change should be disapproved and to determine whether 
such longer period is appropriate and publish the reasons for such 
determination.
    (4) Pursuant to section 107 of the Sarbanes-Oxley Act of 2002, 15 
U.S.C.

[[Page 2807]]

7217, section 19(b)(2) of the Act, 15 U.S.C. 78s(b)(2), and section 
19(b)(3) of the Act, 15 U.S.C. 78s(b)(3), to institute proceedings to 
determine whether a proposed rule change of the Public Company 
Accounting Oversight Board should be disapproved and to provide to the 
Public Company Accounting Oversight Board notice of the grounds for 
disapproval under consideration. In addition, pursuant to section 107 
of the Sarbanes-Oxley Act of 2002, 15 U.S.C. 7217, and section 
19(b)(2)(B) of the Act, 15 U.S.C. 78s(b)(2)(B), to extend for a period 
not exceeding 240 days from the date of publication of notice of the 
filing of a proposed rule change pursuant to section 19(b)(1) of the 
Act, 15 U.S.C. 78s(b)(1), the period during which the Commission must 
issue an order approving or disapproving the proposed rule change and 
to determine whether such longer period is appropriate and publish the 
reasons for such determination.
    (5) Pursuant to section 107 of the Sarbanes-Oxley Act of 2002, 15 
U.S.C. 7217, and section 19(b)(3)(C) of the Act, 15 U.S.C. 
78s(b)(3)(C), to temporarily suspend a rule of the Public Company 
Accounting Oversight Board.
* * * * *

    Dated: January 11, 2011.

    By the Commission.
Elizabeth M. Murphy,
Secretary.
[FR Doc. 2011-835 Filed 1-14-11; 8:45 am]
BILLING CODE 8011-01-P